🎉 M&A multiples are live!
Check it out!

Lumexa Imaging Holdings Valuation Multiples

Discover revenue and EBITDA valuation multiples for Lumexa Imaging Holdings and similar public comparables like Australian Clinical Labs, Healius, and Clarity Pharmaceuticals.

Lumexa Imaging Holdings Overview

About Lumexa Imaging Holdings

Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists’ interpretations of those studies.


Founded

2025

HQ

United States of America
Employees

5.0K+

Financials

LTM Revenue $1.0B

LTM EBITDA $228M

EV

$2.7B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Lumexa Imaging Holdings Financials

As of January 2026, Lumexa Imaging Holdings reported last 12-month revenue of $1.0B and EBITDA of $228M.

In the same period, Lumexa Imaging Holdings generated $158M in LTM gross profit and -$16.2M in net income.

See Lumexa Imaging Holdings valuation multiples based on analyst estimates

Lumexa Imaging Holdings P&L

In the most recent fiscal year, Lumexa Imaging Holdings reported revenue of $949M and EBITDA of $114M.

Lumexa Imaging Holdings expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Lumexa Imaging Holdings valuation multiples based on analyst estimates
LTM NTM Last FY FY 2026 FY 2027 FY 2028
Revenue $1.0B XXX $949M XXX XXX XXX
Gross Profit $158M XXX $96.3M XXX XXX XXX
Gross Margin 16% XXX 10% XXX XXX XXX
EBITDA $228M XXX $114M XXX XXX XXX
EBITDA Margin 22% XXX 12% XXX XXX XXX
EBIT $120M XXX -$16.3M XXX XXX XXX
EBIT Margin 12% XXX -2% XXX XXX XXX
Net Profit -$16.2M XXX -$94.1M XXX XXX XXX
Net Margin -2% XXX -10% XXX XXX XXX
Net Debt XXX XXX $1.2B XXX XXX XXX

Financial data powered by Morningstar, Inc.

Lumexa Imaging Holdings Stock Performance

Lumexa Imaging Holdings has current market cap of $1.4B, and EV of $2.7B.

Market Cap Evolution

Lumexa Imaging Holdings Stock Data

As of February 20, 2026, Lumexa Imaging Holdings's stock price is $14.

See Lumexa Imaging Holdings trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.7B $1.4B XXX XXX XXX XXX $-0.17

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Lumexa Imaging Holdings Valuation Multiples

Lumexa Imaging Holdings's trades at 2.6x EV/Revenue multiple, and 11.7x EV/EBITDA.

See valuation multiples for Lumexa Imaging Holdings and 15K+ public comps

Lumexa Imaging Holdings Financial Valuation Multiples

As of February 20, 2026, Lumexa Imaging Holdings has market cap of $1.4B and EV of $2.7B.

Equity research analysts estimate Lumexa Imaging Holdings's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Lumexa Imaging Holdings has a P/E ratio of -83.2x.

LTM NTM Last FY FY 2026 FY 2027 FY 2028
Market cap (current) $1.4B XXX $1.4B XXX XXX XXX
EV (current) $2.7B XXX $2.7B XXX XXX XXX
EV/Revenue 2.6x XXX 2.6x XXX XXX XXX
EV/EBITDA 11.7x XXX 11.7x XXX XXX XXX
EV/EBIT 22.2x XXX 22.2x XXX XXX XXX
EV/Gross Profit 16.8x XXX n/a XXX XXX XXX
P/E -83.2x XXX -14.4x XXX XXX XXX
EV/FCF -191.0x XXX -191.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Lumexa Imaging Holdings Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Lumexa Imaging Holdings Margins & Growth Rates

Lumexa Imaging Holdings's last 12 month revenue growth is 5%

Lumexa Imaging Holdings's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $22K for the same period.

Lumexa Imaging Holdings's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Lumexa Imaging Holdings's rule of X is 34% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Lumexa Imaging Holdings and other 15K+ public comps

Lumexa Imaging Holdings Operational Valuation Multiples

LTM NTM Last FY FY 2026 FY 2027 FY 2028
Revenue Growth 5% XXX 5% XXX XXX XXX
EBITDA Margin 22% XXX 22% XXX XXX XXX
EBITDA Growth 4% XXX 55% XXX XXX XXX
Rule of 40 15% XXX 27% XXX XXX XXX
Bessemer Rule of X XXX XXX 34% XXX XXX XXX
Revenue per Employee XXX XXX $0.2M XXX XXX XXX
Opex per Employee XXX XXX $22K XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 12% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Lumexa Imaging Holdings Public Comps

See public comps and valuation multiples for Medical Imaging & Diagnostics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Australian Clinical Labs XXX XXX XXX XXX XXX XXX
Clarity Pharmaceuticals XXX XXX XXX XXX XXX XXX
CurveBeam AI XXX XXX XXX XXX XXX XXX
Cyclopharm XXX XXX XXX XXX XXX XXX
Healius XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Lumexa Imaging Holdings M&A and Investment Activity

Lumexa Imaging Holdings acquired  XXX companies to date.

Last acquisition by Lumexa Imaging Holdings was  XXXXXXXX, XXXXX XXXXX XXXXXX . Lumexa Imaging Holdings acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Lumexa Imaging Holdings

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Lumexa Imaging Holdings

When was Lumexa Imaging Holdings founded? Lumexa Imaging Holdings was founded in 2025.
Where is Lumexa Imaging Holdings headquartered? Lumexa Imaging Holdings is headquartered in United States of America.
How many employees does Lumexa Imaging Holdings have? As of today, Lumexa Imaging Holdings has 5.0K+ employees.
Who is the CEO of Lumexa Imaging Holdings? Lumexa Imaging Holdings's CEO is Ms. Caitlin Zulla.
Is Lumexa Imaging Holdings publicy listed? Yes, Lumexa Imaging Holdings is a public company listed on NAS.
What is the stock symbol of Lumexa Imaging Holdings? Lumexa Imaging Holdings trades under LMRI ticker.
When did Lumexa Imaging Holdings go public? Lumexa Imaging Holdings went public in 2025.
Who are competitors of Lumexa Imaging Holdings? Similar companies to Lumexa Imaging Holdings include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm.
What is the current market cap of Lumexa Imaging Holdings? Lumexa Imaging Holdings's current market cap is $1.4B
What is the current revenue of Lumexa Imaging Holdings? Lumexa Imaging Holdings's last 12 months revenue is $1.0B.
What is the current revenue growth of Lumexa Imaging Holdings? Lumexa Imaging Holdings revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Lumexa Imaging Holdings? Current revenue multiple of Lumexa Imaging Holdings is 2.6x.
Is Lumexa Imaging Holdings profitable? Yes, Lumexa Imaging Holdings is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Lumexa Imaging Holdings? Lumexa Imaging Holdings's last 12 months EBITDA is $228M.
What is Lumexa Imaging Holdings's EBITDA margin? Lumexa Imaging Holdings's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of Lumexa Imaging Holdings? Current EBITDA multiple of Lumexa Imaging Holdings is 11.7x.
What is the current FCF of Lumexa Imaging Holdings? Lumexa Imaging Holdings's last 12 months FCF is -$13.9M.
What is Lumexa Imaging Holdings's FCF margin? Lumexa Imaging Holdings's last 12 months FCF margin is -1%.
What is the current EV/FCF multiple of Lumexa Imaging Holdings? Current FCF multiple of Lumexa Imaging Holdings is -191.0x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.